PCAR vs RCUS · P/E 25, rev $33.66B vs rev $58.0M
PACCAR Inc (PCAR) versus Arcus Biosciences Inc (RCUS) — a side-by-side from cached financials, not a winner call.
PACCAR Inc (PCAR) is a farm & heavy construction machinery company listed on NASDAQ.
Arcus Biosciences Inc (RCUS) is a biotechnology company listed on US.
Latest reported PCAR revenue for 2024-12-31 was $33.66B. Net income was $4.16B. Revenue was down 4.2% from 2023-12-31 to 2024-12-31. PCAR currently screens at market cap $61.75B and trailing P/E 25.0.
Latest reported RCUS revenue for 2026-06-30 was $58.0M. Net income was -$219.0M. RCUS currently screens at market cap $885.2M.
PCAR currently screens at market cap $61.75B and trailing P/E 25.0. RCUS currently screens at market cap $885.2M.
Not investment advice. Open the PCAR and RCUS stock pages for the full models.
Not investment advice.